Melanoma trials in Austria

In Austria 10 Also abroad 578

10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Dabrafenib and/or Trametinib Rollover Study
Where
Innsbruck
Age
18 years to 100 years
People
100 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00
Phase 2/3Taking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Graz
Age
18 years and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
Phase 2Not yet taking people in Austria
PHOENIX - ECP: Extracorporeal PHotopheresis for immune-related cOlitis and/or hEpatitis in advanced melaNoma with inadequate response to steroId eXposure
Where
Graz, Salzburg, Vienna
Age
18 years and over
People
46 worldwide
Run by
Therakos Europe Limited
See details and how to join2026-526261-14-00 · EU 2026-526261-14-00
Phase 3Enrolling by invitation
A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
Where
Graz
Age
18 years and over
People
100 worldwide
Run by
Aura Biosciences
See details and how to joinNCT07338968 · EU 2025-524405-33-00
No phaseTaking people
Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy
Where
Gratwein
Age
18 years and over
People
50
Run by
Medical University of Graz
See details and how to joinNCT07635732
Phase 3Taking people
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Where
Graz, Innsbruck, Vienna
Age
18 years and over
People
520 worldwide
Run by
IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00
Phase 3Taking people
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Where
Graz, Linz, Salzburg, Vienna
Age
18 years and over
People
540 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT05549297 · EU 2022-502732-39-00
Phase 3Taking people
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Where
Graz, Pölten, Salzburg, Vienna
Age
18 years and over
People
680 worldwide
Run by
Immunocore Ltd
See details and how to joinNCT06112314
No phaseTaking people
Retrospective Register for Uveal Melanoma
Where
Vienna
Age
18 years to 99 years
People
1,400
Run by
Medical University of Vienna
See details and how to joinNCT05733728
No phaseTaking people
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Where
Graz, Innsbruck, Klagenfurt, Linz, Salzburg, Vienna, Wiener Neustadt
Age
18 years and over
People
750 worldwide
Run by
Pierre Fabre Pharma GmbH
See details and how to joinNCT04045691